Dr. Patrick Shane McElgunn, MD

Dr. McElgunn practices at Piedmont Plastic Surgery & Dermatology PA in Gastonia, North Carolina.

Dr. McElgunn's NPI, 1831148485, was assigned on May 10, 2006. Dr. McElgunn holds North Carolina license 200600105.

Dr. McElgunn's primary practice is Piedmont Plastic Surgery & Dermatology PA, at 1072 X Ray Dr, Gastonia, NC 28054 in Gaston County. The practice phone is (704) 671-1094.

Dr. McElgunn's primary practice is Piedmont Plastic Surgery & Dermatology PA in Gastonia, North Carolina. The medical group on file is Piedmont Plastic Surgery & Dermatology. Dmand AI also links Dr. McElgunn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McElgunn practices. Vendor and product names are available with a free account.

Dermatology is Dr. McElgunn's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. McElgunn's licenses on file in 2 states: North Carolina and Maryland.

CMS data shows 11,881 Medicare services from Dr. McElgunn across 28 procedure codes in 2024, for 1,433 Medicare patients. Medicare paid $567,044 for them. Every service was in an office.

CMS counts 1,433 Medicare patients who saw Dr. McElgunn in 2024. The largest group is 65 to 74, with 655 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McElgunn's median patient age at 64, with 42% women.

In 2024, Dr. McElgunn wrote 2,172 Medicare Part D claims for 827 patients. 91% of them were for generic drugs. CMS names the drug for 2,010 of them, across 26 drugs with 11 or more claims each, at $723,683 in total drug cost. In 2023, CMS named 1,722 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McElgunn for performance year 2024, reported as part of a group. Dr. McElgunn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,841 procedures of removal of skin lesions by Dr. McElgunn, more than 99% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. McElgunn to 3 clinical trials. Conditions studied include Eczema and Dermatitis, Atopic. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. McElgunn that name 2 trials.

CMS Open Payments shows 1,419 general payments to Dr. McElgunn from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Abbvie Inc. paid the most, $129,141. It also lists 11 research payments totaling $37,694 from 2016 to 2023, naming 2 clinical trials.